Shopping Cart 0
Cart Subtotal
AED 0

Middle East and Africa Syndromic Multiplex Diagnostic Market - Industry Trends and Forecast to 2027

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 12845

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 15414

Details

Middle East and Africa syndromic multiplex diagnostic market is projected to register a substantial CAGR in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation

Middle East and Africa Syndromic Multiplex Diagnostic Market, By Products and Services (Reagents & Consumables, Instruments & Accessories and Software & Services), Infection Type (Viral, Bacterial, Parasites, Fungal and Others), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Hepatitis, Tropical Fever, Meningitis, Childhood Infections, Immunosuppression and Eye Infections), Panels Type (Respiratory Panel, GI-Enteric Panel, Sexually Transmitted Disease Panel, Blood-Sepsis Panel, Meningitis Panel and Others), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Physician Office Lab's and Others), Country (South Africa and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Middle East and Africa syndromic multiplex diagnostic market are:

Increasing demand for accurate and fast diagnostic results.

Improving diagnosis seeking rate.

Market Players:

The key market players for Middle East and Africa syndromic multiplex diagnostic market are listed below:

GenMark Diagnostics, Inc.

QuantuMDx Group Ltd.

BioFire Diagnostics (a subsidiary of bioMerieux SA)

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

QIAGEN

Hologic, Inc.

F. Hoffmann-La Roche Ltd

BD

Danaher

Curetis

Abbott

DiaSorin S.p.A.

Bosch Healthcare Solutions GmbH (a subsidiary of Robert Bosch GmbH)

Biocartis

Luminex Corporation

Seegene Inc.

READ MORE

Table Of Content

Scope

TABLE OF CONTENTS

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS AND SERVICES LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.10 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 GROWING PREVALENCE OF INFECTION DISEASES

5.1.2 GROWING ADOPTION OF MOLECULAR DIAGNOSTICS

5.1.3 INCREASING REGULATORY APPROVAL FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) TESTING

5.1.4 INCREASING DEMAND FOR ACCURATE AND FAST DIAGNOSTIC RESULTS

5.1.5 IMPROVING DIAGNOSIS SEEKING RATE

5.2 RESTRAINTS

5.2.1 HIGH COST OF DIAGNOSTIC PRODUCTS

5.2.2 EXPLICIT LIMITATION OF SYNDROMIC MULTIPLEX DIAGNOSTIC

5.3 OPPORTUNITIES

5.3.1 INCREASING DIAGNOSTIC HEALTHCARE EXPENDITURE

5.3.2 INTRODUCTION OF TECHNOLOGICALLY ADVANCED PRODUCTS

5.4 CHALLENGES

5.4.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF DIAGNOSTIC PRODUCTS

5.4.2 LACK OF SKILLED PROFESSIONALS AND BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS

6 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET

6.1 IMPACT ANALYSIS ON DEMAND

6.2 CONCLUSION

7 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES

7.1 OVERVIEW

7.2 REAGENTS & CONSUMABLES

7.3 INSTRUMENTS & ACCESSORIES

7.4 SOFTWARE & SERVICES

8 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE

8.1 OVERVIEW

8.2 VIRAL

8.2.1 RHINOVIRUS

8.2.2 ROTAVIRUS

8.2.3 ADENOVIRUS

8.2.4 CORONAVIRUS

8.2.5 OTHERS

8.3 BACTERIAL

8.3.1 PNEUMONIAE

8.3.2 BORDETELLA PERTUSSIS

8.3.3 STAPHYLOCOCCUS

8.3.4 OF OTHERS

8.4 PARASITES

8.5 FUNGAL

8.6 OTHERS

9 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE

9.1 OVERVIEW

9.2 RESPIRATORY INFECTIONS

9.3 GASTROENTERITIS

9.4 SEXUALLY TRANSMITTED INFECTIONS

9.5 HEPATITIS

9.6 TROPICAL FEVER

9.7 MENINGITIS

9.8 CHILDHOOD INFECTIONS

9.9 IMMUNOSUPPRESSION

9.10 EYE INFECTIONS

10 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE

10.1 OVERVIEW

10.2 RESPIRATORY PANEL

10.3 GI-ENTERIC PANEL

10.4 SEXUALLY TRANSMITTED DISEASE PANEL

10.5 BLOOD-SEPSIS PANEL

10.6 MENINGITIS PANEL

10.7 OTHERS

11 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER

11.1 OVERVIEW

11.2 HOSPITALS

11.3 CLINICAL LABORATORIES

11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

11.5 RESEARCH INSTITUTES

11.6 PHYSICIAN OFFICE LAB'S

11.7 OTHERS

12 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY GEOGRAPHY

12.1 MIDDLE EAST AND AFRICA

12.1.1 SOUTH AFRICA

12.1.2 REST OF MIDDLE EAST AND AFRICA

13 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 BIOFIRE DIAGNOSTICS (A SUBSIDIARY OF BIOMERIEUX SA)

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 SIEMENS HEALTHCARE GMBH

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 F. HOFFMANN-LA ROCHE LTD

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENT

15.4 THERMO FISHER SCIENTIFIC INC.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 BD

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 SEEGENE INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 ABBOTT

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENT

15.8 APPLIED BIOCODE, INC.

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENTS

15.9 BIOCARTIS

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.9.4 RECENT DEVELOPMENT

15.10 BIO-RAD LABORATORIES, INC.

15.10.1 COMPANY SNAPSHOT

15.10.2 REVENUE ANALYSIS

15.10.3 PRODUCT PORTFOLIO

15.10.4 RECENT DEVELOPMENT

15.11 BOSCH HEALTHCARE SOLUTIONS GMBH (A SUBSIDIARY OF ROBERT BOSCH GMBH)

15.11.1 COMPANY SNAPSHOT

15.11.2 REVENUE ANALYSIS

15.11.3 PRODUCT PORTFOLIO

15.11.4 RECENT DEVELOPMENT

15.12 CURETIS

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 DANAHER

15.13.1 COMPANY SNAPSHOT

15.13.2 REVENUE ANALYSIS

15.13.3 PRODUCT PORTFOLIO

15.13.4 RECENT DEVELOPMENT

15.14 DIASORIN S.P.A.

15.14.1 COMPANY SNAPSHOT

15.14.2 REVENUE ANALYSIS

15.14.3 PRODUCT PORTFOLIO

15.14.4 RECENT DEVELOPMENTS

15.15 GENMARK DIAGNOSTICS, INC.

15.15.1 COMPANY SNAPSHOT

15.15.2 REVENUE ANALYSIS

15.15.3 PRODUCT PORTFOLIO

15.15.4 RECENT DEVELOPMENTS

15.16 HOLOGIC, INC.

15.16.1 COMPANY SNAPSHOT

15.16.2 REVENUE ANALYSIS

15.16.3 PRODUCT PORTFOLIO

15.16.4 RECENT DEVELOPMENTS

15.17 LUMINEX CORPORATION

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENT

15.18 NANOMIX, INC.

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENTS

15.19 PROMINEX

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENT

15.20 QIAGEN

15.20.1 COMPANY SNAPSHOT

15.20.2 REVENUE ANALYSIS

15.20.3 PRODUCT PORTFOLIO

15.20.4 RECENT DEVELOPMENT

15.21 QUANTUMDX GROUP LTD.

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS


List Of Figure

LIST OF FIGURES

FIGURE 1 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET : MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION

FIGURE 10 GROWING PREVALENCE OF INFECTION DISEASES AND GROWING ADOPTION OF MOLECULAR DIAGNOSTICS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN THE FORECAST PERIOD OF 2020 TO 2027

FIGURE 11 REAGENTS & CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN 2020 & 2027

FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET

FIGURE 13 PREVALENCE OF CHRONIC DISEASES

FIGURE 14 PERCENTAGE OF DEATHS WORLDWIDE

FIGURE 15 TOTAL CASES OF CORONAVIRUS IN NORTH AMERICA

FIGURE 16 TOTAL CASES OF CORONAVIRUS IN EUROPE

FIGURE 17 TOTAL CASES OF CORONAVIRUS IN ASIA-PACIFIC

FIGURE 18 TOTAL CASES OF CORONAVIRUS IN SOUTH AMERICA

FIGURE 19 TOTAL CASES OF CORONAVIRUS IN MIDDLE EAST AND AFRICA

FIGURE 20 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS

FIGURE 21 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, 2019

FIGURE 22 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, 2019-2027 (USD MILLION)

FIGURE 23 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, CAGR (2020-2027)

FIGURE 24 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE

FIGURE 25 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2019

FIGURE 26 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2019-2027 (USD MILLION)

FIGURE 27 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, CAGR (2020-2027)

FIGURE 28 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, LIFELINE CURVE

FIGURE 29 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2019

FIGURE 30 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2019-2027 (USD MILLION)

FIGURE 31 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, CAGR (2020-2027)

FIGURE 32 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, LIFELINE CURVE

FIGURE 33 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, 2019

FIGURE 34 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, 2019-2027 (USD MILLION)

FIGURE 35 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, CAGR (2020-2027)

FIGURE 36 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, LIFELINE CURVE

FIGURE 37 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2019

FIGURE 38 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2019-2027 (USD MILLION)

FIGURE 39 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, CAGR (2020-2027)

FIGURE 40 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE

FIGURE 41 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SNAPSHOT (2019)

FIGURE 42 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2019)

FIGURE 43 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2020 & 2027)

FIGURE 44 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2020 & 2027)

FIGURE 45 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES (2018-2027)

FIGURE 46 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY SHARE 2019 (%)


List Of Table

LIST OF TABLES

TABLE 1 COST OF THE PRODUCT

TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 3 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA REAGENTS & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA INSTRUMENTS & ACCESSORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA SOFTWARE & SERVICES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA PARASITES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA FUNGAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA RESPIRATORY INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA GASTROENTERITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA HEPATITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA TROPICAL FEVER IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA MENINGITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA CHILDHOOD INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA IMMUNOSUPPRESSION IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA EYE INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, LIFELINE CURVE, 2018-2027 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA RESPIRATORY PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA GI-ENTERIC PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASE PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA BLOOD-SEPSIS PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA MENINGITIS PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA RESEARCH INSTITUTES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA PHYSICIAN OFFICE LAB'S IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 47 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)

TABLE 48 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 49 SOUTH AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 50 SOUTH AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 51 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)

TABLE 52 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)

TABLE 53 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 54 REST OF MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

GenMark Diagnostics, Inc.

QuantuMDx Group Ltd.

BioFire Diagnostics (a subsidiary of bioMerieux SA)

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

QIAGEN

Hologic, Inc.

F. Hoffmann-La Roche Ltd

BD

Danaher

Curetis

Abbott

DiaSorin S.p.A.

Bosch Healthcare Solutions GmbH (a subsidiary of Robert Bosch GmbH)

Biocartis

Luminex Corporation

Seegene Inc.

Company Profile

Company Profile Title

Middle East and Africa syndromic multiplex diagnostic market is projected to register a substantial CAGR in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation

Middle East and Africa Syndromic Multiplex Diagnostic Market, By Products and Services (Reagents & Consumables, Instruments & Accessories and Software & Services), Infection Type (Viral, Bacterial, Parasites, Fungal and Others), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Hepatitis, Tropical Fever, Meningitis, Childhood Infections, Immunosuppression and Eye Infections), Panels Type (Respiratory Panel, GI-Enteric Panel, Sexually Transmitted Disease Panel, Blood-Sepsis Panel, Meningitis Panel and Others), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Physician Office Lab's and Others), Country (South Africa and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the Middle East and Africa syndromic multiplex diagnostic market are:

Increasing demand for accurate and fast diagnostic results.

Improving diagnosis seeking rate.

Market Players:

The key market players for Middle East and Africa syndromic multiplex diagnostic market are listed below:

GenMark Diagnostics, Inc.

QuantuMDx Group Ltd.

BioFire Diagnostics (a subsidiary of bioMerieux SA)

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

QIAGEN

Hologic, Inc.

F. Hoffmann-La Roche Ltd

BD

Danaher

Curetis

Abbott

DiaSorin S.p.A.

Bosch Healthcare Solutions GmbH (a subsidiary of Robert Bosch GmbH)

Biocartis

Luminex Corporation

Seegene Inc.

READ MORE

Scope

TABLE OF CONTENTS

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS AND SERVICES LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.10 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 GROWING PREVALENCE OF INFECTION DISEASES

5.1.2 GROWING ADOPTION OF MOLECULAR DIAGNOSTICS

5.1.3 INCREASING REGULATORY APPROVAL FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) TESTING

5.1.4 INCREASING DEMAND FOR ACCURATE AND FAST DIAGNOSTIC RESULTS

5.1.5 IMPROVING DIAGNOSIS SEEKING RATE

5.2 RESTRAINTS

5.2.1 HIGH COST OF DIAGNOSTIC PRODUCTS

5.2.2 EXPLICIT LIMITATION OF SYNDROMIC MULTIPLEX DIAGNOSTIC

5.3 OPPORTUNITIES

5.3.1 INCREASING DIAGNOSTIC HEALTHCARE EXPENDITURE

5.3.2 INTRODUCTION OF TECHNOLOGICALLY ADVANCED PRODUCTS

5.4 CHALLENGES

5.4.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF DIAGNOSTIC PRODUCTS

5.4.2 LACK OF SKILLED PROFESSIONALS AND BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS

6 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET

6.1 IMPACT ANALYSIS ON DEMAND

6.2 CONCLUSION

7 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES

7.1 OVERVIEW

7.2 REAGENTS & CONSUMABLES

7.3 INSTRUMENTS & ACCESSORIES

7.4 SOFTWARE & SERVICES

8 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE

8.1 OVERVIEW

8.2 VIRAL

8.2.1 RHINOVIRUS

8.2.2 ROTAVIRUS

8.2.3 ADENOVIRUS

8.2.4 CORONAVIRUS

8.2.5 OTHERS

8.3 BACTERIAL

8.3.1 PNEUMONIAE

8.3.2 BORDETELLA PERTUSSIS

8.3.3 STAPHYLOCOCCUS

8.3.4 OF OTHERS

8.4 PARASITES

8.5 FUNGAL

8.6 OTHERS

9 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE

9.1 OVERVIEW

9.2 RESPIRATORY INFECTIONS

9.3 GASTROENTERITIS

9.4 SEXUALLY TRANSMITTED INFECTIONS

9.5 HEPATITIS

9.6 TROPICAL FEVER

9.7 MENINGITIS

9.8 CHILDHOOD INFECTIONS

9.9 IMMUNOSUPPRESSION

9.10 EYE INFECTIONS

10 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE

10.1 OVERVIEW

10.2 RESPIRATORY PANEL

10.3 GI-ENTERIC PANEL

10.4 SEXUALLY TRANSMITTED DISEASE PANEL

10.5 BLOOD-SEPSIS PANEL

10.6 MENINGITIS PANEL

10.7 OTHERS

11 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER

11.1 OVERVIEW

11.2 HOSPITALS

11.3 CLINICAL LABORATORIES

11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

11.5 RESEARCH INSTITUTES

11.6 PHYSICIAN OFFICE LAB'S

11.7 OTHERS

12 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY GEOGRAPHY

12.1 MIDDLE EAST AND AFRICA

12.1.1 SOUTH AFRICA

12.1.2 REST OF MIDDLE EAST AND AFRICA

13 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 BIOFIRE DIAGNOSTICS (A SUBSIDIARY OF BIOMERIEUX SA)

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 SIEMENS HEALTHCARE GMBH

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 F. HOFFMANN-LA ROCHE LTD

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENT

15.4 THERMO FISHER SCIENTIFIC INC.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 BD

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 SEEGENE INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 ABBOTT

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENT

15.8 APPLIED BIOCODE, INC.

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENTS

15.9 BIOCARTIS

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.9.4 RECENT DEVELOPMENT

15.10 BIO-RAD LABORATORIES, INC.

15.10.1 COMPANY SNAPSHOT

15.10.2 REVENUE ANALYSIS

15.10.3 PRODUCT PORTFOLIO

15.10.4 RECENT DEVELOPMENT

15.11 BOSCH HEALTHCARE SOLUTIONS GMBH (A SUBSIDIARY OF ROBERT BOSCH GMBH)

15.11.1 COMPANY SNAPSHOT

15.11.2 REVENUE ANALYSIS

15.11.3 PRODUCT PORTFOLIO

15.11.4 RECENT DEVELOPMENT

15.12 CURETIS

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 DANAHER

15.13.1 COMPANY SNAPSHOT

15.13.2 REVENUE ANALYSIS

15.13.3 PRODUCT PORTFOLIO

15.13.4 RECENT DEVELOPMENT

15.14 DIASORIN S.P.A.

15.14.1 COMPANY SNAPSHOT

15.14.2 REVENUE ANALYSIS

15.14.3 PRODUCT PORTFOLIO

15.14.4 RECENT DEVELOPMENTS

15.15 GENMARK DIAGNOSTICS, INC.

15.15.1 COMPANY SNAPSHOT

15.15.2 REVENUE ANALYSIS

15.15.3 PRODUCT PORTFOLIO

15.15.4 RECENT DEVELOPMENTS

15.16 HOLOGIC, INC.

15.16.1 COMPANY SNAPSHOT

15.16.2 REVENUE ANALYSIS

15.16.3 PRODUCT PORTFOLIO

15.16.4 RECENT DEVELOPMENTS

15.17 LUMINEX CORPORATION

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENT

15.18 NANOMIX, INC.

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENTS

15.19 PROMINEX

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENT

15.20 QIAGEN

15.20.1 COMPANY SNAPSHOT

15.20.2 REVENUE ANALYSIS

15.20.3 PRODUCT PORTFOLIO

15.20.4 RECENT DEVELOPMENT

15.21 QUANTUMDX GROUP LTD.

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS


List Of Figure

LIST OF FIGURES

FIGURE 1 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET : MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SEGMENTATION

FIGURE 10 GROWING PREVALENCE OF INFECTION DISEASES AND GROWING ADOPTION OF MOLECULAR DIAGNOSTICS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN THE FORECAST PERIOD OF 2020 TO 2027

FIGURE 11 REAGENTS & CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET IN 2020 & 2027

FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET

FIGURE 13 PREVALENCE OF CHRONIC DISEASES

FIGURE 14 PERCENTAGE OF DEATHS WORLDWIDE

FIGURE 15 TOTAL CASES OF CORONAVIRUS IN NORTH AMERICA

FIGURE 16 TOTAL CASES OF CORONAVIRUS IN EUROPE

FIGURE 17 TOTAL CASES OF CORONAVIRUS IN ASIA-PACIFIC

FIGURE 18 TOTAL CASES OF CORONAVIRUS IN SOUTH AMERICA

FIGURE 19 TOTAL CASES OF CORONAVIRUS IN MIDDLE EAST AND AFRICA

FIGURE 20 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS

FIGURE 21 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, 2019

FIGURE 22 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, 2019-2027 (USD MILLION)

FIGURE 23 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, CAGR (2020-2027)

FIGURE 24 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES, LIFELINE CURVE

FIGURE 25 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2019

FIGURE 26 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, 2019-2027 (USD MILLION)

FIGURE 27 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, CAGR (2020-2027)

FIGURE 28 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY INFECTION TYPE, LIFELINE CURVE

FIGURE 29 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2019

FIGURE 30 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, 2019-2027 (USD MILLION)

FIGURE 31 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, CAGR (2020-2027)

FIGURE 32 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY DISEASE, LIFELINE CURVE

FIGURE 33 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, 2019

FIGURE 34 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, 2019-2027 (USD MILLION)

FIGURE 35 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, CAGR (2020-2027)

FIGURE 36 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PANELS TYPE, LIFELINE CURVE

FIGURE 37 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2019

FIGURE 38 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, 2019-2027 (USD MILLION)

FIGURE 39 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, CAGR (2020-2027)

FIGURE 40 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE

FIGURE 41 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: SNAPSHOT (2019)

FIGURE 42 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2019)

FIGURE 43 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2020 & 2027)

FIGURE 44 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY COUNTRY (2020 & 2027)

FIGURE 45 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: BY PRODUCTS AND SERVICES (2018-2027)

FIGURE 46 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET: COMPANY SHARE 2019 (%)


List Of Table

LIST OF TABLES

TABLE 1 COST OF THE PRODUCT

TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 3 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA REAGENTS & CONSUMABLES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA INSTRUMENTS & ACCESSORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA SOFTWARE & SERVICES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA PARASITES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA FUNGAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA RESPIRATORY INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA GASTROENTERITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA HEPATITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA TROPICAL FEVER IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA MENINGITIS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA CHILDHOOD INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA IMMUNOSUPPRESSION IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA EYE INFECTIONS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, LIFELINE CURVE, 2018-2027 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA RESPIRATORY PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA GI-ENTERIC PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA SEXUALLY TRANSMITTED DISEASE PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA BLOOD-SEPSIS PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA MENINGITIS PANEL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA HOSPITALS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA CLINICAL LABORATORIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA RESEARCH INSTITUTES IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA PHYSICIAN OFFICE LAB'S IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA OTHERS IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 47 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)

TABLE 48 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 49 SOUTH AFRICA VIRAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 50 SOUTH AFRICA BACTERIAL IN SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY INFECTION TYPE, 2018-2027 (USD MILLION)

TABLE 51 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY DISEASE, 2018-2027 (USD MILLION)

TABLE 52 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PANELS TYPE, 2018-2027 (USD MILLION)

TABLE 53 SOUTH AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 54 REST OF MIDDLE EAST AND AFRICA SYNDROMIC MULTIPLEX DIAGNOSTIC MARKET, BY PRODUCTS AND SERVICES, 2018-2027 (USD MILLION)

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

GenMark Diagnostics, Inc.

QuantuMDx Group Ltd.

BioFire Diagnostics (a subsidiary of bioMerieux SA)

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

QIAGEN

Hologic, Inc.

F. Hoffmann-La Roche Ltd

BD

Danaher

Curetis

Abbott

DiaSorin S.p.A.

Bosch Healthcare Solutions GmbH (a subsidiary of Robert Bosch GmbH)

Biocartis

Luminex Corporation

Seegene Inc.